Neogen Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Neogen Corporation (NEOG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 6.20 million shares for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-07-30
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-11-30 was 1.69M shares, a 330.36% increase year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-08-31 was 0.00 shares.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-05-31 was 614.61K shares, a 332.82% increase year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-02-28 was -391.61K shares, a 763.74% decline year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2026 was 6.20M shares, a 210.00% increase from fiscal 2025.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.00M shares, a 5.26% increase from fiscal 2024.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.90M shares, a 11.50% increase from fiscal 2023.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.70M shares, a 177.07% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | 6.20M shares 10-K · filed 2026-07-30 | ||||
| 2025-05-31 | 2.00M shares 10-K · filed 2026-07-30 | 2.00M shares 10-K · filed 2025-07-30 | |||
| 2024-05-31 | 1.90M shares 10-K · filed 2026-07-30 | 1.95M shares 10-K · filed 2024-07-30 | |||
| 2023-05-31 | 1.70M shares 10-K · filed 2025-07-30 | ||||
| 2022-11-30 | 1.69M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | 1.69M shares 10-Q · filed 2023-01-09 | 2.30M shares derived: sum of 3 quarters · filed 2024-07-30 | 1.91M shares derived: sum of 4 quarters · filed 2024-07-30 | |
| 2022-08-31 | 0.00 shares 10-Q · filed 2022-09-30 | 614.61K shares derived: sum of 2 quarters · filed 2024-07-30 | 223.00K shares derived: sum of 3 quarters · filed 2024-07-30 | 615.00K shares derived: sum of 4 quarters · filed 2024-07-30 | |
| 2022-05-31 | 614.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | 223.00K shares derived: sum of 2 quarters · filed 2024-07-30 | 615.00K shares derived: sum of 3 quarters · filed 2024-07-30 | 615.00K shares 10-K · filed 2024-07-30 | |
| 2022-02-28 | -391.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | 393.00 shares derived: sum of 2 quarters · filed 2022-04-01 | 393.00 shares 10-Q · filed 2022-04-01 | 142.39K shares derived: sum of 4 quarters · filed 2023-08-15 | |
| 2021-11-30 | 392.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-30 | 392.00K shares 10-Q · filed 2021-12-30 | 534.00K shares derived: sum of 3 quarters · filed 2023-08-15 | 593.00K shares derived: sum of 4 quarters · filed 2023-08-15 | |
| 2021-08-31 | 0.00 shares 10-Q · filed 2021-09-30 | 142.00K shares derived: sum of 2 quarters · filed 2023-08-15 | 201.00K shares derived: sum of 3 quarters · filed 2023-08-15 | 403.00K shares derived: sum of 4 quarters · filed 2023-08-15 | |
| 2021-05-31 | 142.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | 201.00K shares derived: sum of 2 quarters · filed 2023-08-15 | 403.00K shares derived: sum of 3 quarters · filed 2023-08-15 | 403.00K shares 10-K · filed 2023-08-15 | |
| 2021-02-28 | 59.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | 261.00K shares derived: sum of 2 quarters · filed 2021-03-31 | 261.00K shares 10-Q · filed 2021-03-31 | 824.00K shares derived: sum of 4 quarters · filed 2022-07-27 | |
| 2020-11-30 | 202.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | 202.00K shares 10-Q · filed 2020-12-29 | 765.00K shares derived: sum of 3 quarters · filed 2022-07-27 | 765.00K shares derived: sum of 4 quarters · filed 2022-07-27 | |
| 2020-08-31 | 0.00 shares 10-Q · filed 2020-09-30 | 563.00K shares derived: sum of 2 quarters · filed 2022-07-27 | 563.00K shares derived: sum of 3 quarters · filed 2022-07-27 | 1.12M shares derived: sum of 4 quarters · filed 2022-07-27 | |
| 2020-05-31 | 563.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | 563.00K shares derived: sum of 2 quarters · filed 2022-07-27 | 1.12M shares derived: sum of 3 quarters · filed 2022-07-27 | 1.12M shares 10-K · filed 2022-07-27 | 562.00K shares 10-K · filed 2020-07-30 |
| 2020-02-29 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | 561.00K shares derived: sum of 2 quarters · filed 2020-04-03 | 561.00K shares 10-Q · filed 2020-04-03 | -525.13M shares derived: sum of 4 quarters · filed 2021-07-30 | |
| 2019-11-30 | 561.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | 561.00K shares 10-Q · filed 2019-12-27 | -525.13M shares derived: sum of 3 quarters · filed 2021-07-30 | -524.13M shares derived: sum of 4 quarters · filed 2021-07-30 | |
| 2019-08-31 | 0.00 shares 10-Q · filed 2019-09-26 | -525.70M shares derived: sum of 2 quarters · filed 2021-07-30 | -524.70M shares derived: sum of 3 quarters · filed 2021-07-30 | 1.05M shares derived: sum of 4 quarters · filed 2021-07-30 | |
| 2019-05-31 | -525.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | -524.70M shares derived: sum of 2 quarters · filed 2021-07-30 | 1.05M shares derived: sum of 3 quarters · filed 2021-07-30 | 1.05M shares 10-K · filed 2021-07-30 | 527.00K shares 10-K · filed 2019-07-30 |
| 2019-02-28 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | 526.75M shares derived: sum of 2 quarters · filed 2019-03-29 | 526.75M shares 10-Q · filed 2019-03-29 | 526.76M shares derived: sum of 4 quarters · filed 2020-07-30 | |
| 2018-11-30 | 525.75M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | 525.75M shares 10-Q · filed 2018-12-28 | 525.76M shares derived: sum of 3 quarters · filed 2020-07-30 | 525.76M shares derived: sum of 4 quarters · filed 2020-07-30 | |
| 2018-08-31 | 0.00 shares 10-Q · filed 2018-10-05 | 10.00K shares derived: sum of 2 quarters · filed 2020-07-30 | 10.00K shares derived: sum of 3 quarters · filed 2020-07-30 | 754.00K shares derived: sum of 4 quarters · filed 2020-07-30 | |
| 2018-05-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | 10.00K shares derived: sum of 2 quarters · filed 2020-07-30 | 754.00K shares derived: sum of 3 quarters · filed 2020-07-30 | 829.00K shares 10-K · filed 2020-07-30 | |
| 2018-02-28 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | 744.00K shares derived: sum of 2 quarters · filed 2018-03-29 | 819.00K shares 10-Q · filed 2018-03-29 | 1.03M shares derived: sum of 4 quarters · filed 2019-07-30 | |
| 2017-11-30 | 744.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | 819.00K shares 10-Q · filed 2018-01-05 | 1.03M shares derived: sum of 3 quarters · filed 2019-07-30 | 1.04M shares derived: sum of 4 quarters · filed 2019-07-30 | |
| 2017-08-31 | 75.00K shares 10-Q · filed 2017-09-29 | 285.00K shares derived: sum of 2 quarters · filed 2019-07-30 | 296.00K shares derived: sum of 3 quarters · filed 2019-07-30 | 903.00K shares derived: sum of 4 quarters · filed 2019-07-30 | |
| 2017-05-31 | 210.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | 221.00K shares derived: sum of 2 quarters · filed 2019-07-30 | 828.00K shares derived: sum of 3 quarters · filed 2019-07-30 | 828.00K shares 10-K · filed 2019-07-30 | 621.00K shares 10-K · filed 2017-07-28 |
| 2017-02-28 | 11.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | 618.00K shares derived: sum of 2 quarters · filed 2017-03-31 | 618.00K shares 10-Q · filed 2017-03-31 | 801.00K shares derived: sum of 4 quarters · filed 2018-07-27 | |
| 2016-11-30 | 607.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | 607.00K shares 10-Q · filed 2016-12-29 | 790.00K shares derived: sum of 3 quarters · filed 2018-07-27 | 790.00K shares derived: sum of 4 quarters · filed 2018-07-27 | |
| 2016-08-31 | 0.00 shares 10-Q · filed 2016-09-30 | 183.00K shares derived: sum of 2 quarters · filed 2018-07-27 | 183.00K shares derived: sum of 3 quarters · filed 2018-07-27 | 732.00K shares derived: sum of 4 quarters · filed 2018-07-27 | |
| 2016-05-31 | 183.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | 183.00K shares derived: sum of 2 quarters · filed 2018-07-27 | 732.00K shares derived: sum of 3 quarters · filed 2018-07-27 | 732.00K shares 10-K · filed 2018-07-27 | 549.00K shares 10-K · filed 2016-07-29 |
| 2016-02-29 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | 549.00K shares derived: sum of 2 quarters · filed 2016-03-31 | 549.00K shares 10-Q · filed 2016-03-31 | 555.00K shares derived: sum of 4 quarters · filed 2017-07-28 | |
| 2015-11-30 | 549.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | 549.00K shares 10-Q · filed 2016-01-08 | 555.00K shares derived: sum of 3 quarters · filed 2017-07-28 | 569.00K shares derived: sum of 4 quarters · filed 2017-07-28 | |
| 2015-08-31 | 0.00 shares 10-Q · filed 2015-09-30 | 6.00K shares derived: sum of 2 quarters · filed 2017-07-28 | 20.00K shares derived: sum of 3 quarters · filed 2017-07-28 | 536.00K shares derived: sum of 4 quarters · filed 2017-07-28 | |
| 2015-05-31 | 6.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | 20.00K shares derived: sum of 2 quarters · filed 2017-07-28 | 536.00K shares derived: sum of 3 quarters · filed 2017-07-28 | 536.00K shares 10-K · filed 2017-07-28 | |
| 2015-02-28 | 14.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | 530.00K shares derived: sum of 2 quarters · filed 2015-04-01 | 530.00K shares 10-Q · filed 2015-04-01 | ||
| 2014-11-30 | 516.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | 516.00K shares 10-Q · filed 2014-12-30 | |||
| 2014-08-31 | 0.00 shares 10-Q · filed 2014-09-30 | ||||
| 2014-05-31 | 512.00K shares 10-K · filed 2016-07-29 | ||||
| 2013-05-31 | 459.00K shares 10-K · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |